Market Place
Sourcing Support
4P-Pharma Adds Three Independent Board Members
10 Sep 2024 //
BUSINESSWIRE
4P-Pharma raises €15M; Oncotelic Therapeutics sells rights to cancer assets
29 Apr 2024 //
ENDPTS
4P-Pharma Secures €15M Total Capital in Second Closing
29 Apr 2024 //
BUSINESSWIRE
Jérôme Vailland Joins 4P-Pharma as Chief Financial Officer
14 Mar 2024 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.